EVOLUS, INC. Income Taxes Paid
EVOLUS, INC. (EOLS) reported Income Taxes Paid of $230.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05
- EVOLUS, INC. income taxes paid, net for the quarter ending 2026-06-30 was $200.00K, a 26.20% decline year-over-year.
- EVOLUS, INC. income taxes paid, net for the quarter ending 2026-03-31 was $30.00K, a 34.78% decline year-over-year.
- EVOLUS, INC. income taxes paid, net for the quarter ending 2025-12-31 was $743.00K, a 1805.13% increase year-over-year.
- EVOLUS, INC. income taxes paid, net for the quarter ending 2025-09-30 was $155.00K, a 384.38% increase year-over-year.
- EVOLUS, INC. income taxes paid, net for fiscal 2025 was $1.22M, a 417.02% increase from fiscal 2024.
- EVOLUS, INC. income taxes paid, net for fiscal 2024 was $235.00K, a 100.85% increase from fiscal 2023.
- EVOLUS, INC. income taxes paid, net for fiscal 2023 was $117.00K, a 53.95% increase from fiscal 2022.
- EVOLUS, INC. income taxes paid, net for fiscal 2022 was $76.00K, a 442.86% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $230.00K 10-Q · filed 2026-08-05 | $973.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-04 | $773.00K derived: sum of 2 quarters · filed 2026-05-04 | $928.00K derived: sum of 3 quarters · filed 2026-05-04 | $1.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $743.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $898.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.17M derived: sum of 3 quarters · filed 2026-08-05 | $1.22M 10-K · filed 2026-03-03 |
| 2025-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $426.00K derived: sum of 2 quarters · filed 2026-08-05 | $472.00K 10-Q · filed 2025-11-05 | $511.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $271.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $317.00K 10-Q · filed 2026-08-05 | $356.00K derived: sum of 3 quarters · filed 2026-08-05 | $388.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $46.00K 10-Q · filed 2026-05-04 | $85.00K derived: sum of 2 quarters · filed 2026-05-04 | $117.00K derived: sum of 3 quarters · filed 2026-05-04 | $255.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $71.00K derived: sum of 2 quarters · filed 2026-03-03 | $209.00K derived: sum of 3 quarters · filed 2026-03-03 | $235.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $170.00K derived: sum of 2 quarters · filed 2025-11-05 | $196.00K 10-Q · filed 2025-11-05 | $218.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $164.00K 10-Q · filed 2025-08-05 | $186.00K derived: sum of 3 quarters · filed 2026-03-03 | $225.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $26.00K 10-Q · filed 2025-05-07 | $48.00K derived: sum of 2 quarters · filed 2026-03-03 | $87.00K derived: sum of 3 quarters · filed 2026-03-03 | $116.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $61.00K derived: sum of 2 quarters · filed 2026-03-03 | $90.00K derived: sum of 3 quarters · filed 2026-03-03 | $117.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $68.00K derived: sum of 2 quarters · filed 2024-11-06 | $95.00K 10-Q · filed 2024-11-06 | $101.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $56.00K 10-Q · filed 2024-07-31 | $62.00K derived: sum of 3 quarters · filed 2025-03-04 | $78.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $27.00K 10-Q · filed 2024-05-07 | $33.00K derived: sum of 2 quarters · filed 2025-03-04 | $49.00K derived: sum of 3 quarters · filed 2025-03-04 | $103.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $22.00K derived: sum of 2 quarters · filed 2025-03-04 | $76.00K derived: sum of 3 quarters · filed 2025-03-04 | $76.00K 10-K · filed 2025-03-04 |
| 2022-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $70.00K derived: sum of 2 quarters · filed 2023-11-07 | $70.00K 10-Q · filed 2023-11-07 | $84.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $54.00K 10-Q · filed 2023-08-02 | $68.00K derived: sum of 3 quarters · filed 2023-08-02 | $68.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $14.00K derived: sum of 2 quarters · filed 2023-05-09 | $14.00K derived: sum of 3 quarters · filed 2023-05-09 | |
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $14.00K derived: sum of 2 quarters · filed 2023-03-08 | $14.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-02 | |||
| 2020-12-31 | $65.00K 10-K · filed 2022-03-03 | |||
| 2019-12-31 | $4.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |